Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 279-283, July 2007

Assisted Peritoneal Dialysis

  • Johan V. Povlsen

      Affiliations

    • Corresponding Author InformationAddress correspondence to Johan V. Povlsen, Department of Renal Medicine C, Aarhus University Hospital, Skejby, DK-8200 Aarhus, Denmark.
  • ,
  • Per Ivarsen

Department of Renal Medicine C, Aarhus University Hospital, Skejby, Aarhus, Denmark.

Elderly patients are the largest and fastest growing group of patients with chronic kidney disease maintained on dialysis in the world. Because of advanced age and a heavy burden of comorbidities, the elderly are usually not candidates for kidney transplantation and are less likely to be offered peritoneal dialysis (PD). There is, however, growing evidence that the use of community nurses to assist with PD and the introduction of programs for assisted peritoneal dialysis (aPD) targeting these frail, elderly patients may enable more elderly patients to have their PD treatment at home. Suitable candidates for aPD are incident end-stage kidney disease patients preferring PD but unable to perform their own treatment because of comorbidities, physical disabilities, or psychosocial problems; prevalent, previous autonomous PD patients who have lost their independence because of advanced age or an increased burden of comorbidities; or prevalent hemodialysis (HD) patients switched from HD to aPD because of their own preference, failure of vascular access for HD, or an inability to tolerate HD. We believe that aPD in the future will prove to be a safe and feasible complementary alternative to in-center HD for the growing group of frail, elderly patients with end-stage kidney disease.

Index Words: Assisted peritoneal dialysis, assisted automated peritoneal dialysis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported in part by an unrestricted grant from Baxter, Renal Division, Denmark.

PII: S1548-5595(07)00052-3

doi:10.1053/j.ackd.2007.03.008

Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 279-283, July 2007